| Quercetin with the potential effect on allergic diseases M Jafarinia, M Sadat Hosseini, N Kasiri, N Fazel, F Fathi, ... Allergy, Asthma & Clinical Immunology 16, 1-11, 2020 | 182 | 2020 |
| Immune system changes during COVID-19 recovery play key role in determining disease severity F Fathi, R Sami, S Mozafarpoor, H Hafezi, H Motedayyen, R Arefnezhad, ... International Journal of Immunopathology and Pharmacology 34, 2058738420966497, 2020 | 44 | 2020 |
| Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study N Firouzabadi, N Ghazanfari, A Alavi Shoushtari, N Erfani, F Fathi, ... PloS one 11 (4), e0153667, 2016 | 35 | 2016 |
| Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients M Ahmadi, F Fathi, S Fouladi, F Alsahebfosul, M Manian, N Eskandari Current Molecular Medicine 19 (5), 357-363, 2019 | 25 | 2019 |
| Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? R Sami, F Fathi, N Eskandari, M Ahmadi, R ArefNezhad, H Motedayyen Cytokine 140, 155439, 2021 | 23 | 2021 |
| Association of programmed death‐1 gene polymorphisms with the risk of basal cell carcinoma F Fathi, M Ebrahimi, A Eslami, H Hafezi, N Eskandari, H Motedayyen International journal of immunogenetics 46 (6), 444-450, 2019 | 22 | 2019 |
| MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis M Fattahi, N Rezaei, FS Nematalahi, V Shaygannejad, S Fouladi, L Karimi, ... Multiple sclerosis and related disorders 35, 241-245, 2019 | 20 | 2019 |
| The effect of lipopolysaccharide on anti-inflammatory and pro-inflammatory cytokines production of human amniotic epithelial cells H Motedayyen, F Fathi, M Fasihi-Ramandi, RA Taheri Reproductive biology 18 (4), 404-409, 2018 | 19 | 2018 |
| Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus F Fathi, A Atapour, N Eskandari, N Keyhanmehr, H Hafezi, S Mohammadi, ... International journal of immunopathology and pharmacology 33, 2058738419863238, 2019 | 18 | 2019 |
| Iron oxide/gold nanoparticles-decorated reduced graphene oxide nanohybrid as the thermo-radiotherapy agent K Moloudi, H Samadian, M Jaymand, E Khodamoradi, ... IET nanobiotechnology 14 (5), 428-432, 2020 | 17 | 2020 |
| Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma F Fathi, B Zamani, A Piroozmand, S Mozafarpoor, E Seyedhashemi, ... Molecular biology reports 48, 2047-2052, 2021 | 15 | 2021 |
| Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus F Fathi, E Sadeghi, N Lotfi, H Hafezi, M Ahmadi, S Mozafarpoor, ... International journal of immunogenetics 47 (1), 57-64, 2020 | 15 | 2020 |
| A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019 M Shabani, BS Ehdaei, F Fathi, R Dowran New Microbes and New Infections 42, 100895, 2021 | 12 | 2021 |
| PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck NEAG Farshid Fathi, Zahra Faghih, Bijan Khademi, Toomaj Kayedi Immunological Investigations, 2018 | 12* | 2018 |
| Toll-like receptor 4 activation on human amniotic epithelial cells is a risk factor for pregnancy loss H Motedayyen, F Fathi, M Fasihi-Ramandi, AM Sabzghabaee, RA Taheri Journal of Research in Medical Sciences 24 (1), 1, 2019 | 10 | 2019 |
| Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing–Remitting Multiple Sclerosis Patients M Golabi, F Fathi, M Samadi, MS Hesamian, N Eskandari Inflammation 45 (4), 1815-1828, 2022 | 7 | 2022 |
| Liver resection promotes (regulates) proinflammatory cytokines in patients with hepatocellular carcinoma F Fathi, B Sanei, M Ganjalikhani Hakemi, RF Saidi, A Rezaei Canadian Journal of Gastroenterology and Hepatology 2021 (1), 5593655, 2021 | 7 | 2021 |
| Current advances in stem cell therapy in the treatment of multiple sclerosis P Zolfaghari Baghbadorani, A Rayati Damavandi, S Moradi, M Ahmadi, ... Reviews in the Neurosciences 34 (6), 613-633, 2023 | 6 | 2023 |
| Changes in immune profile affect disease progression in hepatocellular carcinoma F Fathi, RF Saidi, HR Banafshe, M Arbabi, M Lotfinia, H Motedayyen International Journal of Immunopathology and Pharmacology 36, 03946320221078476, 2022 | 6 | 2022 |
| The Association of Programmed Death 1 Gene Polymorphisms of PD1. 3 G/A and PD1. 5 C/T with Risk of COVID-19 in an Iranian Population: A Case–Control Study A Rayati Damavandi, P Zolfaghari Baghbadorani, B Kardideh, ... Viral immunology 35 (7), 483-490, 2022 | 4 | 2022 |